← Back to all products
Retatrutide 20mg vial — research peptideFEATURED

Retatrutide

20mg/vial · Triple GIP/GLP-1/Glucagon Agonist — Extended Protocol

฿4,500
LINEWhatsApp
Purity >98%Keep RefrigeratedResearch Use Only

About this peptide

Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 clinical trials demonstrated up to 24.2% mean body weight reduction at 48 weeks — the highest efficacy reported among investigational peptides.The glucagon receptor component adds direct hepatic fat oxidation, making it uniquely potent for metabolic research.

⚠️ For research use only.

Frequently Asked Questions

  • Retatrutide 20mg is a higher-dose format of the triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon (GCG) pathways. This vial provides double the quantity of our standard 10mg offering for extended research protocols. Lotus Labs supplies Retatrutide at >98% purity for laboratory research only.